Show simple item record

dc.contributor.authorWambugu, Paul Wachira
dc.date.accessioned2015-05-28T12:12:28Z
dc.date.available2015-05-28T12:12:28Z
dc.date.issued2012-11
dc.identifier.urihttp://ir-library.ku.ac.ke/handle/123456789/12724
dc.descriptionMasters in business administration (strategic management option),55p november,2012, HD 9667.5 .W3en_US
dc.description.abstractThe relevance of monitoring, understanding and responding to competitors has long been recognized as a significant aspect of marketing activity. Yet analysis of the competitive environment seems often to be subordinated as greater emphasis is placed on understanding consumers. Clearly important though customers are, they should not dominate marketing strategy and planning. Competition in the Kenyan Pharmaceutical Industry continually work to drive down the rate of return on capital invested. The pharmaceutical companies have thus resulted in making use of various competitive intelligence aspects to ensure profitability. The study generally sought to analyze the effects of competitive intelligence practices on the performance of pharmaceutical companies in Nairobi. Specifically, the study sought to establish the effect of product intelligence strategies, new markets intelligence, technology intelligence, strategic alliance intelligence and on the performance of pharmaceutical companies in Nairobi. The study adopted a descriptive survey design. The method is chosen since it is more precise and accurate since it involves description of events in a carefully planned way and also portrays the characteristics of a population fully. The study targeted managers of pharmaceutical distribution companies in Nairobi. For the smaller firms, the target respondents were the owners/managers or the superintending pharmacists or their designate. In larger corporations, the managers at the time being in charge of distribution, their equivalents or their designate was targeted. From the population sampling frame the required number of subjects/ respondents was selected through stratified proportionate random sampling technique based on whether they bare wholesalers, manufacturer or retailers. Primary data was obtained through use of questionnaires. Quantitative data collected using a questionnaire was analyzed by the use of descriptive statistics while the qualitative data was analyzed using content analysis. In addition, the researcher conducted a multiple regression analysis so as to determine the relationship between the company's profitability and the four competitive intelligence practices. This research helped the companies to remain competitive and profitable amidst the current stiff competition witnessed in the pharmaceutical sector. The study found that the company employed new market intelligence as a competitive intelligence. Product intelligence influenced the performance of the company to a great extent. The company initiated activities to obtain information on technology advancement in the industry to a very great extent. Mergers in the industry and strategic alliance enhanced the performance of the company to a very great extent. The study concludes that the company employed new market intelligence as a competitive intelligence. Product intelligence influenced the performance ofthe company to a great extent. The company initiated activities to obtain information on process automation in the firm, interconnected technology in the company, integrated systems in the industry and new software in the industry. Joint venture in the industry and acquisitions in the industry enhanced the performance of the company. The study recommends pharmaceutical companies to employ new market intelligence. The study recommends the managers in pharmaceutical companies to adopt product diversification intelligence. The company should initiate activities to obtain information on technology advancement in the industry. They need to form mergers so as to enhance the performance of the company.en_US
dc.description.sponsorshipKenyatta University.en_US
dc.language.isoenen_US
dc.titleAn analysis of the effects of competitive intelligence practices on the performance of pharmaceutical companies in Nairobien_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record